Antimicrobial Agents and Chemotherapy · 2008 · 15 citations · 18 references
PharmacyPharmacokineticsPharmacologyAntimicrobial PharmacotherapyDrug MetabolismHepatic PharmacokineticsAntifungal AgentsAntifungal PharmacologyAntifungal PharmacotherapyAntifungal TherapyCytochrome P450 InteractionsFungal MetabolismAspergillosis TherapyBacterial Meningitis TreatmentCentral Nervous System Antifungal TherapyCentral Nervous System Fungal InfectionCerebral AspergillosisCyp2c19 PharmacogeneticsInvasive Aspergillosis TreatmentPediatric Antifungal Dosing
For an adolescent with bacterial meningitis and subsequent cerebral aspergillosis, intravenous voriconazole dose requirements substantially decreased during coadministration with intravenous chloramphenicol and considerably rose after discontinuation of the antibiotic. In agreement with in vitro evidence, these data suggest that chloramphenicol is a rather significant inhibitor of hepatic CYP3A4 and/or CYP2C19.
18
Voriconazole Therapeutic Drug Monitoring
Jeannina A. Smith, Nasia Safdar, V. Knasinski et al. · Antimicrobial Agents and Chemotherapy · 2006 · 400 citations · Full text
Nina Singh, Ajit P. Limaye, Graeme N. Forrest et al. · Transplantation · 2006 · 340 citations
Pharmacy, Pharmacotherapy, Antimicrobial Pharmacotherapy +16